GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Life Science Corp (XKRX:234080) » Definitions » Sale Of Investment

JW Life Science (XKRX:234080) Sale Of Investment : ₩8,019 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is JW Life Science Sale Of Investment?

JW Life Science's sale of investment for the three months ended in Mar. 2024 was ₩8,019 Mil. It means JW Life Science gained ₩8,019 Mil from selling investments. JW Life Science's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was ₩8,019 Mil.

Compared with last quarter (₩0 Mil in Dec. 2023 ), JW Life Science gained more money from selling investments in Mar. 2024 (₩8,019 Mil).


JW Life Science Sale Of Investment Historical Data

The historical data trend for JW Life Science's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Life Science Sale Of Investment Chart

JW Life Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 13,637.73 38,215.98

JW Life Science Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25,015.98 - - - 8,019.31

JW Life Science Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩8,019 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JW Life Science Sale Of Investment Related Terms

Thank you for viewing the detailed overview of JW Life Science's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


JW Life Science (XKRX:234080) Business Description

Traded in Other Exchanges
N/A
Address
28, Hanjin 1-gil, Songak-eup, Dangjin-si, Chungcheongnam-do, Seoul, KOR, 343-823
JW Life Science Corp develops and produces infusion solutions. Its products contents amino acids, lipids, proteins, vitamins, and minerals to patients.

JW Life Science (XKRX:234080) Headlines

No Headlines